Managing Director/ CEO Usman Akram Leads Staff Training on EU MDR Compliance at Acheron Instruments (Pvt.) Ltd.

Lahore, Pakistan - April 23, 2026 - Acheron Instruments (Pvt.) Ltd. recently held a comprehensive informational workshop, led by Managing Director/CEO Usman Akram, to educate employees on the vital importance of the European Union Medical Device Regulation  (EU MDR) to the surgical instruments industry. The session also provided staff with practical training on key compliance procedures and regulatory requirements. 

During the educational workshop, the company proudly announced that it has secured an extension letter from its notified body, ensuring regulatory compliance and continued market access through 2028, and confirmed that preparations are already underway for the Stage 1 audit as part of the ongoing certification process. Mr Usman Akram also highlighted the appointment of its authorized European Union representative to facilitate regulatory coordination and ensure full compliance with EU requirements.

The internal workshop thoroughly explored the operational specifics required by the new regulations, placing a strong emphasis on the critical distinctions, handling procedures, and manufacturing requirements for both sterile and non-sterile instruments. The company has fully implemented the comprehensive medical device framework and currently operates under the Class 1 and Class 1 (R) classifications. 

To support these rigorous compliance efforts, Acheron Instruments maintains robust quality and risk management systems, proudly holding ISO 13485 and ISO 14971 certifications to ensure the consistent quality and safety of its medical devices. In addition, our company is certified by major regulatory authorities, including the US FDA, Saudi FDA, MHRA (UK), and TGA (Australia), further demonstrating its commitment to global regulatory compliance and high manufacturing standards.

Addressing the broader economic landscape, Mr. Usman Akram also emphasized that Pakistan exports more than $500 million in surgical instruments annually. There are approximately 5,500 registered companies in SIMAP as manufacturers and exporters by value, with 1,800 to 2,000 considered active members. This significant economic contribution underscores the absolute necessity for local manufacturers to strictly adhere to evolving international standards. Furthermore, the Managing Director/CEO detailed that the ongoing shift from the Medical Device Directive (MDD) to the stricter Medical Device Regulation (MDR) represents a major change for the healthcare supply chain.

A critical portion of the presentation was dedicated to clarifying the key responsibilities of the notified body under the new regulatory regime. Employees learned how these independent organizations meticulously assess the conformity of medical devices before granting access to the European market. By proactively embracing the enhanced regulatory framework and securing the critical extension until 2028, Acheron Instruments has demonstrated an unwavering commitment to patient safety and product efficacy. This proactive regulatory approach has significantly bolstered the trust of international clients who rely on the company for premium, fully compliant surgical solutions.